Published in Vaccine Weekly, July 15th, 2009
Researchers conducted the study because the cost effectiveness of HPV vaccination may be limited by the low number of cervical cancer cases and deaths in the region associated with the current Dutch cervical cancer screening program.
In the study, Inge M.C.M. de Kok of the Department of Public Health at Erasmus MC, University Medical Center in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly